OrbiMed’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $37.1M | Hold |
|
|||||
|
2024
Q2 | $39.5M | Buy |
|
|||||
|
2024
Q1 | $41.6M | Hold |
|
|||||
|
2023
Q4 | $37.8M | Buy |
|
|||||
|
2023
Q3 | $18.6M | Sell |
|
|||||
|
2023
Q2 | $53M | Buy |
|
|||||
|
2023
Q1 | $36.2M | Sell |
|
|||||
|
2022
Q4 | $51.1M | Hold |
|
|||||
|
2022
Q3 | $48.2K | Sell |
|
|||||
|
2022
Q2 | $44.7K | Buy |
|
|||||
|
2022
Q1 | $37.5M | Buy |
|
|||||
|
2021
Q4 | $43.4M | Buy |
|
|||||
|
2021
Q3 | $3.64M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $26M | Buy |
|
|||||
|
2020
Q3 | $16.1M | Hold |
|
|||||
|
2020
Q2 | $16.2M | Buy |
|
|||||
|
2020
Q1 | $3.18M | Buy |
|
|||||
|
2019
Q4 | $1.86M | Hold |
|
|||||
|
2019
Q3 | $1.58M | Hold |
|
|||||
|
2019
Q2 | $1.97M | Hold |
|
|||||
|
2019
Q1 | $1.11M | Hold |
|
|||||
|
2018
Q4 | $943K | Sell |
|
|||||
|
2018
Q3 | $3.53M | Hold |
|
|||||
|
2018
Q2 | $3.07M | Hold |
|
|||||
|
2018
Q1 | $6.22M | Hold |
|
|||||
|
2017
Q4 | $3.83M | Hold |
|
|||||
|
2017
Q3 | $5.11M | Hold |
|
|||||
|
2017
Q2 | $6.11M | Sell |
|
|||||
|
2017
Q1 | $6.65M | Sell |
|
|||||
|
2016
Q4 | $5.43M | Hold |
|
|||||
|
2016
Q3 | $11.5M | Hold |
|
|||||
|
2016
Q2 | $7.46M | Hold |
|
|||||
|
2016
Q1 | $10.1M | Buy |
|